Med-IQ

Course Listings: Rheumatology

All Results (8)
Format: Live Events (0) Online Activities (8)

Advancing the Education of Rheumatology Fellows and Improving Patient Care

View Course

Format: Webcast

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: In this CME-accredited webcast, recorded at the 2017 American College of Rheumatology annual meeting in San Diego, California, Lisa Criscione-Schreiber, MD, MEd, discusses abstracts on a treat-to-target quality improvement program, a workshop on transitioning pediatric patients to adult care, and a clinical research project on myositis. These abstracts were…More


Pregnancy and Rheumatic Diseases: Improving Patient Outcomes and Alleviating Lactation Concerns

View Course

Format: Webcast

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: In this accredited CME webcast, Megan Clowse, MD, discusses several abstracts by her research groups on the management of pregnant patients with rheumatic diseases, presented at the 2017 American College of Rheumatology annual meeting in San Diego, California. Topics include the relationship between hydroxychloroquine and pregnancy, pregnancy and…More


Skeletal Muscle Molecular Alterations in Patients With Rheumatoid Arthritis

View Course

Format: Webcast

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: In this accredited CME webcast, Kim Huffman, MD, PhD, discusses abstracts presented by her research groups at the 2017 American College of Rheumatology annual meeting in San Diego, California. Topics include the relationship between skeletal muscle cytokines and myostatins before and after physical activity in patients with rheumatoid arthritis; the…More


Decision-IQ: A Case Study in Prosthetic Joint Inflammation

View Course

Format: Decision-IQ

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This brief activity presents a case study discussing a patient with prosthetic joint infection. Links to useful resources are provided to help participants make treatment decisions for this patient.


The Rapidly Evolving Role of Biosimilars: Educating Specialists and Facilitating Shared Decision Making With Patients

View Course

Format: E-Publication

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This accredited CME publication describes biosimilars and how they compare with their originator products, reviews FDA guidance on the biosimilar approval process, and discusses key issues for prescribers. In addition, brief clinical case vignettes present examples of how biosimilars may appear in practice.


Clinical Conundrums in a Patient Presenting With Weight Loss and Multiple Other Complaints: Can You Diagnose This Disease?

View Course

Format: Simulation

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: In this video-enhanced, CME-certified simulation, clinicians are challenged to appropriately diagnose a patient presenting with multiple complaints, including weight loss. Throughout the activity, clinicians must consider the patient’s medical history and physical evaluation and order appropriate laboratory and diagnostic tests to identify and treat his…More


Increasing Physician Awareness of Pulmonary Arterial Hypertension in Systemic Sclerosis

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This online CME publication discusses guideline recommendations for pulmonary arterial hypertension (PAH) screening in patients with systemic sclerosis (SSc) and presents key insights on available treatment options for PAH. In addition, this publication is enhanced with audio clips from an expert roundtable discussion on the increased risk of PAH in SSc, signs…More


Targeting IL-6 Signaling in the Treatment of Rheumatoid Arthritis

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This digital CME publication is based on a Q&A session between Elena M. Massarotti, MD, and William F.C. Rigby, MD, that explored the potential role and benefits of targeting the interleukin 6 (IL-6) pathway to treat moderate-to-severe rheumatoid arthritis (RA). Faculty discuss how IL-6 is involved in the pathophysiology of RA and provide insight on…More